The Future: Think performance enhancers are a problem now?
By David Epstein,
Sports Illustrated
| 03. 11. 2008
Welcome to the era of the genetically engineered superathlete
I am one of the most avid sports fans you'll find," Se-Jin Lee says. It's true. He'll watch anything. Basketball. Football. Fútbol.
Billiards on channel seven-hundred-whatever. As a graduate student in
the '80s Lee used to sit in his car in the driveway with the radio on
to listen to the games of faraway baseball teams. Even now, in his lab
at Johns Hopkins Medical School in Baltimore, he easily rattles off the
NCAA basketball tournament winners in order from 1964 to 2007. And,
like anyone who values fair competition these days, he's disturbed by
the issue of performance-enhancing drugs in sports.
Why, then, is
Lee working to usher in technology that will make even today's most
inventive doping methods look primitive? A professor of molecular
biology and genetics, the 49-year-old Lee studies genes that tell
muscles what to do -- genes that he knows how to change. As clever as
chemists are in altering steroid molecules to avoid detection (recall
BALCO's THG, a.k.a. "the Clear"), those designer drugs can be spotted
once antidoping agencies know what to look for...
Related Articles
By Rob Stein, NPR [cites CGS' Katie Hasson] | 09.29.2026
Cathy Tie slips on a white lab coat bearing her name and the logo of her startup: Origin Genomics. "Welcome!" she says as she leads an NPR reporter, photographer and videographer on an exclusive tour of Origin's labs located...
Artificial Intelligence (AI) has been a major focus of news recently, as it should have been, under the appropriately ridiculous name of Hugging Face, “a leading collaboration platform and community hub for machine learning, artificial intelligence, and data science.” In July, Hugging Face was hacked. The platform itself responded:
Earlier this week, we detected and responded to an intrusion into part of our production infrastructure. This one was different from anything we had handled before in one important way...
By Miryam Naddaf, Nature | 09.21.2026
A wave of epigenetic therapies is offering hope as ways to cure chronic hepatitis B — a lingering liver infection that is caused by the hepatitis B virus (HBV) and affects more than 250 million people around the world. Currently...
By Karen Weintraub, Endpoints News | 09.16.2026
To better understand certain neuropsychiatric disorders, researchers at Stanford University have bred rodents that lack a cortex and hippocampus and then replaced those missing brain cells with human ones.
The altered mice, a scientific first, provided insights that would not...